. Finally, a non-dopaminergic antipsychotic (xanomeline-trospium) for treatment of schizophrenia: Significance and learnings. Asian J Psychiatr. 2024 Nov 19;102:104320. Epub 2024 Nov 19 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.